Search PubMed⌕ Search

Biomedical subjects

K Uchida

Publications and source records attributed to K Uchida.

At least 1,459 records · Page 81Linked to original sources

Aldosterone responsiveness to angiotensin II after sodium restriction in subjects with low renin essential hypertension.

Plasma aldosterone (PA) responses to sodium restriction (25 mEq sodium/day for 4 days) and to graded angiotensin II (AII) infusions (2, 4 and 8 ng/kg/min each for 30 min) during a low sodium intake were studied in 14 subjects with low renin essential hypertension (LREH) versus 16 normotensive subjects. The PA response to sodium restriction in relation to changes in plasma renin activity (PRA) was estimated by the ratio of PA increment to PRA increment after sodium restriction (delta PA/delta PRA). In 8 of 14 LREH subjects, whose delta PA/delta PRA ratios were normal, the PA responses to the graded AII doses were similar to those in the normotensive subjects. However, in the remaining 6 LREH subjects whose delta PA/delta PRA ratios were high the PA responses to the graded AII doses were greater. Apparently some LREH subjects, whose delta PA/delta PRA ratios after sodium restriction were high, have an abnormally enhanced aldosterone responsiveness to AII under the condition of low sodium intake.

Adult↗

Changes of glandular kallikrein activity in human plasma following glucose ingestion.

We studied the changes of glandular kallikrein activity in plasma of nine normal female volunteers, aged 22.2 +/- 1.20 years (mean +/- SEM), following 75 g glucose ingestion along with those of immunoreactive insulin, C-peptide immunoreactivity, free fatty acid and blood glucose using our recently developed assay system for plasma glandular kallikrein activity. Glandular kallikrein activities decreased initially from mean baseline level and then returned to baseline level with the lapse of time after glucose load. Furthermore, in hyperinsulinemic group, mean glandular kallikrein activities at 120 min after glucose load revealed to be significantly higher than those of normoinsulinemic group. The findings suggest that active glandular kallikrein is consumed and utilized during glucose uptake at the peripheral tissues, and hyperinsulinemia brings about prolonged activation of kallikrein-kinin system.

Adult↗

[Clinical management of acute lymphocytic leukemia in adults. 1. Treatment of acute lymphocytic leukemia with VP (vincristine, prednisolone)--DVMP (daunorubicin, vincristine 6-mercaptopurine, prednisolone) regimen].

Eighteen patients with acute lymphocytic leukemia (ALL) were treated with VP (vincristine, prednisolone) followed by DVMP (daunorubicin + vincristine + 6-mercaptopurine + prednisolone) regimen (VP-DVMP regimen). Patients were all previously untreated. Complete remission (CR) was obtained in 11 of 18 patients (61.1%,) by VP alone and 4 patients, by VP-DVMP. The time required for CR varied from 14 to 60 days with a median of 28 days. The duration of CR and survivals in responders were from 1.2 to 42.3 + months with a median of 24.0 months. The hematological toxicities in VP-DVMP regimen were lower than those in NVP (neocarzinostatin + vincristine + prednisolone) and NVMP (neocarzinostatin + vincristine + 6-mercaptopurine + prednisolone) regimens.

Adolescent↗

[Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].

A comparative trial of a combination of daunorubicin and cytosine arabinoside (Regimen A) and a combination of aclarubicin and cytosine arabinoside (Regimen B) was performed. Sixteen patients with acute non-lymphocytic leukemia, previously untreated, were entered into this study. Five of 8 patients (62.5%) obtained a complete remission (CR) in Regimen A and B, respectively. The days required for achieving a CR varied from 37 to 46 days in Regimen A and from 22 to 56 days in Regimen B. The total doses of daunorubicin and cytosine arabinoside were from 100 to 240 mg and from 640 to 1,120 mg in Regimen A, respectively. Those of aclarubicin were from 180 to 300 mg and from 660 to 1,000 mg in cytosine arabinoside in Regimen B. In a comparative study on hematological changes, toxic effects on peripheral white blood cell, platelet and nucleated cell counts in bone marrow tended to appear later in Regimen B compared to those in Regimen A. Side effects on digestive system such as nausea and vomiting and vascular pain were more frequently recognized in patients treated with Regimen B, although they were managed by symptomatic treatment. The results indicated the usefullness of aclarubicin in combination chemotherapy for the treatment of acute non-lymphocytic leukemia.

Aclarubicin↗

[Recovery from cyclophosphamide-induced myelosuppression accelerated by bestatin].

In this experiment, the effect of bestatin on cyclophosphamide (CYC)-induced myelosuppression was studied to evaluate the hemopoietic activity. Bestatin administrated i.p. from -day 5 to -day 1, showed no influence on the peripheral blood pictures and bone marrow nucleated cell counts (NCC) in normal mice. On the other hand, in mice treated with CYC, 300 mg/kg, i.p. on day 0, bestatin accelerated the recovery from CYC-induced leukopenia and myelosuppression. The accelerated recovery of the total WBC count and bone marrow NCC were solely due to the enhanced granulocyte recovery. These findings indicated a promising effect of bestatin in the clinical management of myelosuppression induced by cancer chemotherapy.

Aminopeptidases↗

Urinary and fecal keto bile acids in liver cirrhosis.

The urinary and fecal bile acids of thirteen male patients with liver cirrhosis were analyzed by gas chromatography and gas chromatography-mass spectrometry to obtain information on their keto bile acid excretion. 3 alpha-Hydroxy-12-keto-5 beta-cholanoic, 3 alpha,12 alpha-dihydroxy-7-keto-5 beta-cholanoic, 3 alpha,7 alpha-dihydroxy-12-keto-5 beta-cholanoic and 3 alpha-hydroxy-7,12-diketo-5 beta-cholanoic acids were found in the urine of ten patients. In four of these patients, keto bile acids were the main bile acids excreted in the urine. However, the ratios of fecal keto bile acids to the total fecal bile acids in these four patients were similar to those in the other six patients whose urinary excretion of keto bile acids was low. Three of the four patients had clinical abnormalities, such as ascites, esophageal varices or a history of hepatic encephalopathy, that may indicate advanced liver dysfunction and/or presence of collateral circulation. These findings suggest that the occurrence of keto bile acids in the urine might be ascribed to the escape of these acids from reduction to hydroxy-forms in the liver, not to bacterial over-production in the intestine. However, the mechanism and significance of the presence of keto bile acids in the urine are still unknown.

Adult↗

A Golgi analysis of the accessory optic fibers terminating in the medial terminal nucleus of the mouse accessory optic system.

Fibers of the accessory optic tract (AOT) terminating in the medial terminal nucleus (MTN) were observed in the mouse by the rapid Golgi method. The AOT fibers, which entered the MTN from its ventromedial aspect, were divided into thick and fine fiber groups, the thick fibers emitting many terminal collaterals of various calibers, and the fine ones generating fine terminal branches. The possibility exists that the retinal neurons sending AOT fibers to the MTN might be heterogeneous in nature.

Animals↗

Extrageniculate projections to the visual cortex in the macaque monkey: an HRP study.

Extrageniculate projections to the visual cortex were examined in the macaque monkeys by the horseradish peroxidase (HRP) method. Extrageniculate neurons sending fibers to the visual cortex were found in the lateral and inferior pulvinar nuclei, paracentral thalamic nucleus, claustrum, basal nucleus of Meynert, lateral part of the basal amygdaloid nucleus, lateral hypothalamus, locus coeruleus, and dorsomedial and midline regions of the pontine tegmentum.

Animals↗